Upcoming Weight Loss Drugs to Watch in 2026 and Beyond
From oral GLP-1 pills to triple-action injectables, here’s what’s next in obesity treatment The obesity treatment landscape is evolving rapidly,…
Tag: Drugs
Ozempic Copycats Restricted: U.S. Judge Upholds FDA Ruling on Semaglutide Compounding
On April 24, 2025, a U.S. judge rejected a bid by compounding pharmacies to continue producing copies of Novo Nordisk’s…
Orforglipron Pill Price: Affordable Ozempic Alternative?
In 2025, weight loss drugs have taken center stage in global health discussions — and Orforglipron, a new oral GLP-1…
Weight Loss Without Needles? Scientists Developing Obesity Creams and Patches, Says Report
In a remarkable development within the field of obesity medicine, researchers are exploring less invasive alternatives to injectable weight-loss drugs,…
Why Retatrutide Is Changing the Obesity Game in 2025
Retatrutide, an investigational drug developed by Eli Lilly, is making waves in the field of obesity treatment. Currently in clinical…
The Dangerous Duo: How Obesity and Type 2 Diabetes Are Closely Linked
Obesity and type 2 diabetes are often called “twin epidemics” — and for good reason. These two conditions not only…
Orforglipron vs Tirzepatide: A New Chapter in Weight Loss and Diabetes Treatment
Orforglipron and tirzepatide, developed by Eli Lilly, are cutting-edge treatments for type 2 diabetes and obesity. While both aim to…